{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:50:34Z","timestamp":1785153034956,"version":"3.55.0"},"reference-count":39,"publisher":"Georg Thieme Verlag KG","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rofo"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:p>Cervical cancer is still the fourth most common malignancy in women worldwide and has a high mortality rate. The prognosis as well as the therapy depends largely on the extent of the tumor at the time of initial diagnosis. This shows the importance of correct staging of cervical cancer. In order to promote a globally uniform approach, staging of cervical cancer in the past was based on widespread examinations such as exam under anesthesia, histology from cervical conization or biopsy, systematic lymphadenectomy, cystoscopy, proctoscopy, i.\u200av.-pyelogram and chest X-ray. However, as the primary tumor stage was often underestimated, the 2018 revised FIGO classification now permits cross-sectional imaging techniques and pathological findings to be incorporated into disease staging or an already existing stage to be adapted based on radiological findings. Thanks to its excellent soft tissue contrast, magnetic resonance imaging (MRI) is the method of choice for local-regional staging of cervical cancer, evaluating the response to treatment, detecting tumor recurrence and for follow-up examinations. It is important that radiologists interpreting pelvic MRI in case of suspected cervical cancer are familiar with the current FIGO staging system. This is the only way to determine the tumor stage as precisely as possible and thus lay the foundation for the success of therapy for patients. The aim of this review is to present the changes of the revised FIGO classification as well as to show the importance of MRI as the method of choice for local-regional tumor staging as a complement to clinical examination.<\/jats:p><jats:p>\n            Key Points:\u2002<\/jats:p><jats:p>\n            Citation Format\n          <\/jats:p>","DOI":"10.1055\/a-1198-5729","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T22:58:28Z","timestamp":1596149908000},"page":"937-944","source":"Crossref","is-referenced-by-count":38,"title":["Revised FIGO Staging for Cervical Cancer \u2013 A New Role for MRI"],"prefix":"10.1055","volume":"192","author":[{"given":"Johanna","family":"Merz","sequence":"additional","affiliation":[{"name":"Department of Radiology, Freiburg University Hospital, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Bossart","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Freiburg University Hospital, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Bamberg","sequence":"additional","affiliation":[{"name":"Department of Radiology, Freiburg University Hospital, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Eisenblaetter","sequence":"additional","affiliation":[{"name":"Department of Radiology, Freiburg University Hospital, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2020,7,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"N Bhatla","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/1471-0528.13071","article-title":"HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis","volume":"122","author":"L Rodriguez-Carunchio","year":"2015","journal-title":"BJOG"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/cncr.30588","article-title":"Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases","volume":"123","author":"T A Berman","year":"2017","journal-title":"Cancer"},{"key":"ref6","first-page":"728","article-title":"One decade of HPV vaccination in Germany","volume":"56","author":"P Schneede","year":"2017","journal-title":"Urologe A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.4049\/jimmunol.1490012","article-title":"Development and implementation of papillomavirus prophylactic vaccines","volume":"192","author":"I H Frazer","year":"2014","journal-title":"J Immunol"},{"key":"ref8","first-page":"97","article-title":"Mitteilung der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut: Impfung gegen humane Papillomaviren (HPV) f\u00fcr M\u00e4dchen von 12 bis 17 Jahren -Empfehlung und Begr\u00fcndung 2007","volume":"12","author":"R K Institut","year":"2007","journal-title":"Epid\u00a0Bulletin"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.17886\/EpiBull-2018-042.5","article-title":"Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) beim Robert Koch Institut \u2013 2018\/2019","author":"Institut RK","year":"2018","journal-title":"Epid Bull"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"F Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ogc.2012.02.008","article-title":"Cervical cancer","volume":"39","author":"J S Lea","year":"2012","journal-title":"Obstet Gynecol Clin North Am"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1007\/s00261-019-01984-7","article-title":"MRI of cervical cancer with a surgical perspective: staging, prognostic implications and pitfalls","volume":"44","author":"P Balcacer","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s00330-010-1998-x","article-title":"Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology","volume":"21","author":"C Balleyguier","year":"2011","journal-title":"Eur Radiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0090-8258(03)00409-8","article-title":"Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review","volume":"91","author":"S Bipat","year":"2003","journal-title":"Gynecologic Oncology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.mric.2017.03.007","article-title":"MR Imaging of Cervical Cancer","volume":"25","author":"K Patel-Lippmann","year":"2017","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00259-017-3809-y","article-title":"Comparison of (18)F-FDG PET\/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix","volume":"45","author":"T Sarabhai","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1349-7006.2010.01532.x","article-title":"Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography\/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis","volume":"101","author":"H J Choi","year":"2010","journal-title":"Cancer Sci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1148\/radiol.2511081265","article-title":"Uterine Cervical Carcinoma: Preoperative Staging with 3.0-T MR Imaging-Comparison with 1.5-T MR Imaging","volume":"251","author":"M Hori","year":"2009","journal-title":"Radiology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11912-019-0824-0","article-title":"What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?","volume":"21","author":"I S Haldorsen","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.crad.2007.05.007","article-title":"The value of hyoscine butylbromide in pelvic MRI","volume":"62","author":"W Johnson","year":"2007","journal-title":"Clin Radiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0009-9260(98)80098-6","article-title":"Fast dynamic contrast enhanced MR imaging of cervical carcinoma","volume":"53","author":"P B Van Vierzen","year":"1998","journal-title":"Clinical Radiology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s00330-013-2783-4","article-title":"Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma: systematic review and meta-analysis","volume":"23","author":"M G Thomeer","year":"2013","journal-title":"Eur Radiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1148\/radiology.204.1.9205223","article-title":"Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging","volume":"204","author":"K Kinkel","year":"1997","journal-title":"Radiology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ijrobp.2008.08.023","article-title":"Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer","volume":"74","author":"M A Zahra","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1200\/JCO.2006.07.4799","article-title":"Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651\/GOG 183 Intergroup Study","volume":"24","author":"D G Mitchell","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref26","first-page":"449","article-title":"Cervical Cancer: Evaluation and Management","volume":"97","author":"J Wipperman","year":"2018","journal-title":"Am Fam Physician"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.mri.2013.12.007","article-title":"The value of diffusion-weighted MRI to evaluate the response to radiochemotherapy for cervical cancer","volume":"32","author":"F Kuang","year":"2014","journal-title":"Magnetic Resonance Imaging"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00259-017-3898-7","article-title":"Prediction of outcome using pretreatment (18)F-FDG PET\/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy","volume":"45","author":"F Lucia","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0140-6736(03)13778-6","article-title":"Cervical cancer","volume":"361","author":"S E Waggoner","year":"2003","journal-title":"The Lancet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jso.21199","article-title":"Lymph node assessment in cervical cancer: prognostic and therapeutic implications","volume":"99","author":"L T Gien","year":"2009","journal-title":"J Surg Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1148\/radiology.184.1.1609108","article-title":"Cervical Cancer: Serial MR Imaging before and after Primary Radiation Therapy \u2013 A 2-year Follow-up Study","volume":"184","author":"F Flueckiger","year":"1992","journal-title":"Radiology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.mri.2014.05.009","article-title":"Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging","volume":"32","author":"J J Park","year":"2014","journal-title":"Magn Reson Imaging"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jmri.23804","article-title":"Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging","volume":"37","author":"H S Kim","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ygyno.2009.06.001","article-title":"Follow-up for women after treatment for cervical cancer: a systematic review","volume":"114","author":"L Elit","year":"2009","journal-title":"Gynecol Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/IGC.0000000000001009","article-title":"Cervical Adenocarcinoma Has a Poorer Prognosis and a Higher Propensity for Distant Recurrence Than Squamous Cell Carcinoma","volume":"27","author":"E J Jung","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1148\/radiology.189.2.8210364","article-title":"Irradiation of the cervix uteri: value of unenhanced and contrast-enhanced MR imaging","volume":"189","author":"H Hricak","year":"1993","journal-title":"Radiology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1007\/s00261-016-0730-y","article-title":"Can diffusion-weighted magnetic resonance imaging predict tumor recurrence of uterine cervical cancer after concurrent chemoradiotherapy?","volume":"41","author":"J M Bae","year":"2016","journal-title":"Abdom Radiol (NY)"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2967\/jnumed.114.145011","article-title":"Evaluation of gynecologic cancer with MR imaging, 18F-FDG PET\/CT, and PET\/MR imaging","volume":"56","author":"S I Lee","year":"2015","journal-title":"J Nucl Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1148\/radiol.2452061983","article-title":"Early Invasive Cervical Cancer: CT and MR Imaging in Preoperative Evaluation \u2013 ACRIN\/GOG Comparative Study of Diagnostic Performance and Interobserver Variability","volume":"245","author":"H Hricak","year":"2007","journal-title":"Radiology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bpobgyn.2014.04.009","article-title":"Imaging techniques for the evaluation of cervical cancer","volume":"28","author":"A C Testa","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/s00259-015-3131-5","article-title":"Integrated PET\/MRI for whole-body staging of patients with primary cervical cancer: preliminary results","volume":"42","author":"J Grueneisen","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["R\u00f6Fo - Fortschritte auf dem Gebiet der R\u00f6ntgenstrahlen und der bildgebenden Verfahren"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1198-5729.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T22:32:10Z","timestamp":1601418730000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1198-5729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,30]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,9,29]]},"published-print":{"date-parts":[[2020,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1198-5729","relation":{},"ISSN":["1438-9029","1438-9010"],"issn-type":[{"value":"1438-9029","type":"print"},{"value":"1438-9010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,30]]}}}